Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RAYMED LABS vs PROCTER & GAMBLE HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    RAYMED LABS PROCTER & GAMBLE HEALTH RAYMED LABS/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x -11.1 38.8 - View Chart
P/BV x - 16.0 - View Chart
Dividend Yield % 0.0 5.1 -  

Financials

 RAYMED LABS   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    RAYMED LABS
Mar-24
PROCTER & GAMBLE HEALTH
Jun-24
RAYMED LABS/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs25,640 0.0%   
Low Rs24,640 0.0%   
Sales per share (Unadj.) Rs0693.5 0.0%  
Earnings per share (Unadj.) Rs-0.2121.1 -0.2%  
Cash flow per share (Unadj.) Rs-0.2137.6 -0.2%  
Dividends per share (Unadj.) Rs0260.00 0.0%  
Avg Dividend yield %05.1 0.0%  
Book value per share (Unadj.) Rs-5.6319.1 -1.8%  
Shares outstanding (eoy) m4.2716.60 25.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x07.4-  
Avg P/E ratio x-9.442.5 -22.3%  
P/CF ratio (eoy) x-9.937.4 -26.6%  
Price / Book Value ratio x-0.416.1 -2.5%  
Dividend payout %0214.7 -0.0%   
Avg Mkt Cap Rs m1085,323 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m02,152 0.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m011,513 0.0%  
Other income Rs m0156 0.0%   
Total revenues Rs m011,669 0.0%   
Gross profit Rs m-12,858 -0.0%  
Depreciation Rs m0274 0.0%   
Interest Rs m07 0.0%   
Profit before tax Rs m-12,733 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0723 0.0%   
Profit after tax Rs m-12,010 -0.1%  
Gross profit margin %024.8- 
Effective tax rate %026.5 -0.0%   
Net profit margin %017.5- 
BALANCE SHEET DATA
Current assets Rs m09,306 0.0%   
Current liabilities Rs m16,253 0.0%   
Net working cap to sales %026.5- 
Current ratio x01.5 2.6%  
Inventory Days Days0298- 
Debtors Days Days0271- 
Net fixed assets Rs m110,735 0.0%   
Share capital Rs m43166 25.7%   
"Free" reserves Rs m-675,131 -1.3%   
Net worth Rs m-245,297 -0.5%   
Long term debt Rs m00-   
Total assets Rs m220,041 0.0%  
Interest coverage x0380.6-  
Debt to equity ratio x00-  
Sales to assets ratio x00.6 0.0%   
Return on assets %-67.310.1 -668.7%  
Return on equity %4.237.9 11.1%  
Return on capital %4.251.7 8.2%  
Exports to sales %00-  
Imports to sales %069.6-  
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA8,013 0.0%   
Fx inflow Rs m05,421 0.0%   
Fx outflow Rs m08,013 0.0%   
Net fx Rs m0-2,592 -0.0%   
CASH FLOW
From Operations Rs m-12,283 -0.0%  
From Investments Rs m1-69 -0.9%  
From Financial Activity Rs mNA-4,181 -0.0%  
Net Cashflow Rs m0-1,967 -0.0%  

Share Holding

Indian Promoters % 28.4 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 1.0 21.5 4.5%  
FIIs % 0.0 6.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 71.6 48.2 148.7%  
Shareholders   1,497 54,792 2.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare RAYMED LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on RAYMED LABS. vs Procter & Gamble Health

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

RAYMED LABS. vs Procter & Gamble Health Share Price Performance

Period RAYMED LABS. Procter & Gamble Health S&P BSE HEALTHCARE
1-Day 0.00% -0.62% 1.23%
1-Month 0.00% -0.33% -0.24%
1-Year 11.79% -1.57% 43.62%
3-Year CAGR 42.52% 0.56% 20.35%
5-Year CAGR 2.76% 3.69% 26.24%

* Compound Annual Growth Rate

Here are more details on the RAYMED LABS. share price and the Procter & Gamble Health share price.

Moving on to shareholding structures...

The promoters of RAYMED LABS. hold a 28.4% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of RAYMED LABS. and the shareholding pattern of Procter & Gamble Health.

Finally, a word on dividends...

In the most recent financial year, RAYMED LABS. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Procter & Gamble Health paid Rs 260.0, and its dividend payout ratio stood at 214.7%.

You may visit here to review the dividend history of RAYMED LABS., and the dividend history of Procter & Gamble Health.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.